{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:20:36Z","timestamp":1758633636473},"reference-count":31,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T00:00:00Z","timestamp":1336608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>We previously reported a 60% erythroid response rate with recombinant erythropoietin\u00a0+\u00a013\u2010<jats:italic>cis<\/jats:italic> retinoic acid\u00a0+\u00a0dihydroxylated vitamin <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>3 in 63 <jats:italic>elderly<\/jats:italic> myelodysplastic patients (median age 75\u00a0years) with unfavourable features for response to erythropoietin alone [70% transfusion\u2010dependent, 35% refractory anaemia with ring sideroblasts\/refractory anaemia with excess of blasts type 1 (<jats:styled-content style=\"fixed-case\">RAEB<\/jats:styled-content>1), 70% with <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>nternational <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>rognostic <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>coring <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>ystem (<jats:styled-content style=\"fixed-case\">IPSS<\/jats:styled-content>) Intermediate\u20101 or \u20102]. This report updates that <jats:italic>case study<\/jats:italic> at a 7\u2010year follow\u2010up, and compared the impact on overall survival of erythroid response to known prognostic factors. The erythroid response duration (median 17\u00a0months; 22 in non\u2010<jats:styled-content style=\"fixed-case\">RAEB<\/jats:styled-content> patients, with 20% patients in response after 6\u00a0years of therapy) was longer than in most studies with erythropoietin alone. Overall survival (median 55\u00a0months in non\u2010<jats:styled-content style=\"fixed-case\">RAEB<\/jats:styled-content>, 15 in <jats:styled-content style=\"fixed-case\">RAEB<\/jats:styled-content>1 patients) was negatively affected by <jats:styled-content style=\"fixed-case\">RAEB<\/jats:styled-content>1 diagnosis, <jats:styled-content style=\"fixed-case\">IPSS<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">WPSS<\/jats:styled-content> intermediate scores and transfusion\u2010dependence. In the multivariate analysis, erythroid response maintained an independent positive impact on survival, particularly in non\u2010<jats:styled-content style=\"fixed-case\">RAEB<\/jats:styled-content> patients in the first 3\u00a0years from diagnosis (90% survival compared to 50% of non\u2010responders). In conclusion, the long\u2010term follow\u2010up confirmed the achievement, by our combined treatment, of fairly long\u2010lasting erythroid response in the majority of <jats:styled-content style=\"fixed-case\">MDS<\/jats:styled-content> patients with unfavourable prognostic features for response to erythropoietin: this translated in a survival benefit that was independent from other prognostic features.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2012.09125.x","type":"journal-article","created":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T10:24:19Z","timestamp":1336645459000},"page":"99-107","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Long\u2010term follow\u2010up of myelodysplastic syndrome patients with moderate\/severe anaemia receiving human recombinant erythropoietin\u00a0+ 13\u2010<i>cis<\/i>\u2010retinoic acid and dihydroxylated vitamin <scp>D<\/scp>3: independent positive impact of erythroid response on survival"],"prefix":"10.1111","volume":"158","author":[{"given":"Elena","family":"Cris\u00e0","sequence":"first","affiliation":[{"name":"Haematology Division S. Giovanni Battista Hospital University of Turin  Turin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Foli","sequence":"additional","affiliation":[{"name":"Haematology Division Chivasso Hospital  Chivasso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Passera","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Service S. Giovanni Battista Hospital  Turin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Darbesio","sequence":"additional","affiliation":[{"name":"Oncology Division Chivasso Hospital  Chivasso Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly B.","family":"Garvey","sequence":"additional","affiliation":[{"name":"Haematology Division S. Giovanni Battista Hospital University of Turin  Turin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Boccadoro","sequence":"additional","affiliation":[{"name":"Haematology Division S. Giovanni Battista Hospital University of Turin  Turin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Ferrero","sequence":"additional","affiliation":[{"name":"Haematology Division S. Giovanni Battista Hospital University of Turin  Turin"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,5,10]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.22111"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-005-0044-6"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2252"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-4149"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(95)00156-5"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07465.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22343"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.6.2079"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-211797"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04153.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.01085.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.362"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.4906"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.5696"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06070.x"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02016.x"},{"key":"e_1_2_7_18_1","first-page":"236","article-title":"Differentiation therapy in myelodysplastic syndromes","volume":"33","author":"Morosetti R.","year":"1996","journal-title":"Seminars in Hematology"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24090"},{"key":"e_1_2_7_20_1","first-page":"44","article-title":"Adding growth factors or interleukin 3 to erythropoietin has limited effects on anemia of transfusion\u2010dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone","volume":"86","author":"Musto P.","year":"2001","journal-title":"Haematologica"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05288.x"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.10.022"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.10.4076.bloodjournal87104076"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428191003728610"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-096370"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2010.05.030"},{"key":"e_1_2_7_27_1","first-page":"1058","article-title":"Erythropoietin plus granulocyte colony\u2010stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders","volume":"84","author":"Remacha A.F.","year":"1999","journal-title":"Haematologica"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-004-0961-9"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.5.1578"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi400"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-209262"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2011.561834"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2012.09125.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2012.09125.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T05:02:03Z","timestamp":1700542923000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2012.09125.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,10]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.1111\/j.1365-2141.2012.09125.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09125.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,10]]},"assertion":[{"value":"2011-12-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-03-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-05-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}